
|Videos|July 24, 2021
Surgical updates for Bausch + Lomb
Chuck Hess shares an update on Bausch + Lomb's latest developments in surgical technology, as well as how the company has adapted its operations during the pandemic.
Advertisement
Chuck Hess, vice president and general manager, U.S. Surgical (Bausch +Lomb), shares an update on Bausch + Lomb's latest developments in surgical technology — including ClearVisc™, a dispersive ophthalmic viscosurgical device — as well as how the company has adapted its operations during the pandemic.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
3
Recognizing biomarkers of Alzheimer Disease using OCTA
4
Midyear cataract check-in: What 2026 has brought to the OR and beyond
5





















